Lv54
1360 积分 2024-03-18 加入
Mechanisms and treatment of pulmonary arterial hypertension
22天前
已完结
A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism—A Proof-of-Concept Trial
23天前
已完结
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes
24天前
已完结
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma
24天前
已完结
The complement alternative pathway and hemostasis
27天前
已完结
A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results
1个月前
已关闭
Multiple‐dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA‐IgG1), a novel erythropoietic agent, in healthy postmenopausal women
1个月前
已完结
A Phase 2a, Open-Label, Dose-Finding Study To Determine The Safety and Tolerability Of Sotatercept (ACE-011) In Adults With Beta (β)-Thalassemia: Interim Results
1个月前
已关闭
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
1个月前
已完结
皖公网安备34019202002308
